Background and aims: Insulin resistance is among the key risk factors for the development of non-alcoholic fatty liver disease (NAFLD). Recently, it has been reported that GW9662, shown to be a potent peroxisome proliferator-activated receptor gamma (PPARγ) antagonist, may improve insulin sensitivity in settings of type 2 diabetes. Here, we determined the effects of GW9662 on the development of NAFLD and molecular mechanisms involved. Methods: Female C57BL/6J mice were pair-fed either a liquid control diet (C) or a fat-, fructose- and cholesterol-rich diet (FFC) for 8 weeks while either being treated with GW9662 (1 mg/kg body weight; C+GW9662 and FFC+GW9662) or vehicle (C and FFC) i.p. three times weekly. Indices of liver damage and inflamm...
Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have inve...
Non-alcoholic fatty liver disease (NAFLD) defines a wide spectrum of liver diseases that ex-tends fr...
Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have inve...
Abstract Insulin resistance and hepatic lipid accumulation constitute the metabolic underpinning of ...
Alcohol consumption is a major cause of liver disease. It also associates with increased cardiovascu...
Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance. The peroxis...
Non-alcoholic fatty liver disease (NAFLD) defines a wide spectrum of liver diseases that extends fro...
Non-alcoholic fatty liver disease (NAFLD) is a major health issue in developed countries. Although u...
Non-alcoholic fatty liver disease (NAFLD) is a major health issue in developed countries. Although u...
Activation of peroxisome proliferator-activated receptors (PPARs) have been implicated in the treatm...
Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and strongly associated with cent...
Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and strongly associated with cent...
Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have inve...
Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have inve...
Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have inve...
Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have inve...
Non-alcoholic fatty liver disease (NAFLD) defines a wide spectrum of liver diseases that ex-tends fr...
Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have inve...
Abstract Insulin resistance and hepatic lipid accumulation constitute the metabolic underpinning of ...
Alcohol consumption is a major cause of liver disease. It also associates with increased cardiovascu...
Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance. The peroxis...
Non-alcoholic fatty liver disease (NAFLD) defines a wide spectrum of liver diseases that extends fro...
Non-alcoholic fatty liver disease (NAFLD) is a major health issue in developed countries. Although u...
Non-alcoholic fatty liver disease (NAFLD) is a major health issue in developed countries. Although u...
Activation of peroxisome proliferator-activated receptors (PPARs) have been implicated in the treatm...
Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and strongly associated with cent...
Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and strongly associated with cent...
Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have inve...
Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have inve...
Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have inve...
Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have inve...
Non-alcoholic fatty liver disease (NAFLD) defines a wide spectrum of liver diseases that ex-tends fr...
Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have inve...